1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 11 PATRICIA ELIZABETH BLOSE, Case No. 1:22-cv-01651-CDB (SS) 12 Plaintiff, ORDER DENYING PLAINTIFF’S MOTION FOR SUMMARY JUDGMENT 13 v. AND AFFIRMING DECISION OF COMMISSIONER OF SOCIAL 14 COMMISSIONER OF SOCIAL SECURITY, SECURITY 15 Defendant. (Doc. 18) 16 17 Plaintiff Patricia Elizabeth Blose (“Plaintiff”) seeks judicial review of a final decision of 18 the Commissioner of Social Security (“Commissioner” or “Defendant”) denying her application 19 for disability benefits under the Social Security Act (“SSA” or “Act”). (Doc. 1). The matter is 20 before the Court on the Administrative Record (Docs. 11, 17; hereinafter, “AR”) and the parties’ 21 briefs (Docs. 18, 19), which were submitted without oral argument. Upon review of the record, the 22 Court finds and rules as follows.1 23 I. BACKGROUND 24 A. Administrative Proceedings and ALJ’s Decision 25 On April 20, 2020, Plaintiff filed an application under Title II and Title XVIII of the Act 26 for benefits with an alleged onset date of February 21, 2019. (AR 242). Plaintiff’s claim was 27 1 On February 8, 2023, after the parties consented to the jurisdiction of a U.S. Magistrate Judge for all further proceedings pursuant to 28 U.S.C. § 636(c)(1), this action was reassigned to a 1 initially denied on June 30, 2020, and again upon reconsideration on October 7, 2020. (AR 123,
2 130). Plaintiff requested a hearing before an Administrative Law Judge on October 26, 2020. (AR
3 137).
4 Ben Willner, the Administrative Law Judge (“ALJ”), held a hearing on April 8, 2021,
5 wherein Plaintif`f , counsel for Plaintiff Todd Greenwald, and impartial vocational expert (“VE”) 6 Michael DeMark, all testified. (AR 1066). ALJ Willner retired prior to the issuance of a decision 7 and ALJ MaryKay Rauenzahn took over the case, holding a hearing on September 22, 2021, with 8 Plaintiff, counsel Todd Greenwald, and VE Gretchen Bakkenson attending. (AR 41-43). 9 The ALJ issued an unfavorable decision on November 3, 2021, finding Plaintiff was not 10 disabled. (AR 30). The Appeals Council denied Plaintiff’s request for review on November 3, 11 2022, rendering the ALJ’s decision as the final decision of the Commissioner. (AR 1). Plaintiff 12 subsequently filed this action seeking judicial review of the ALJ’s decision. (Doc. 1). 13 In the decision, the ALJ considered Plaintiff’s claims using the five-step sequential 14 evaluation required by 20 C.F.R. § 404.1520(a). (AR 18). The ALJ found that Plaintiff meets the 15 insured status requirements of the Act through December 31, 2021. (AR 19). At step one, the ALJ 16 found that Plaintiff had not engaged in substantial gainful activity since February 21, 2019, the 17 alleged onset date. (AR 20). 18 At step two, the ALJ found that Plaintiff had the following medically determinable 19 impairments (“MDIs”) through the date last insured which significantly limit the ability to perform 20 basic work activities: irritable bowel syndrome (“IBS”)/chronic functional abdominal pain 21 syndrome, recurrent right ankle sprains with talofibular ligament and calcaneofibular ligament 22 tears, status post-surgical repair, obesity, fibromyalgia, lumbar spondylosis, thyroid disorder, and 23 bilateral elbow medial epicondylitis. Id. The ALJ considered the severity of Plaintiff’s mental 24 impairments, considering whether the four broad functional areas of mental functioning listed in 25 the “paragraph B” criteria are satisfied.2 The ALJ found no limitations in the four broad areas of 26 2 The “paragraph B” criteria evaluate mental impairments in the context of four broad areas 27 of functioning: (1) understanding, remembering, or applying information; (2) interacting with others; (3) concentrating, persisting, or maintaining pace; and (4) adapting or managing oneself. 1 functioning. Because Plaintiff’s mental impairments did not cause at least two “marked”
2 limitations or one “extreme” limitation, and do not cause more than minimal limitation in Plaintiff’s
3 ability to perform basic mental work activities, the ALJ found the paragraph B criteria were not
4 satisfied and that the mental impairments are non-severe. (AR 21).
5 At step th` ree, the ALJ found that Plaintiff did not have an impairment, or any combination 6 of impairments, that met or medically equaled the severity of one of the listed impairments in 20 7 C.F.R. Part 404, Subpart P, Appendix 1 (20 C.F.R. §§ 404.1520(d), 404.1525, and 404.1526). (AR 8 22). 9 Prior to step four, the ALJ found that Plaintiff has the RFC to perform a reduced range of 10 light work as defined in 20 C.F.R. 404.1567(b) meaning that: 11 The claimant can lift and carry 20 pounds occasionally and 10 pounds frequently. 12 She can stand and/or walk for approximately six hours and sit for approximately six hours, in an eight-hour workday, with normal breaks. The claimant cannot 13 climb ladders, ropes, and scaffolds and can occasionally climb stairs and ramps. The claimant can occasionally stoop, crouch, kneel, crawl, and balance, as defined 14 by the Selective Characteristics of Occupations of the Dictionary of Occupational Titles (SCO-DOT). She can occasionally push and pull with the right lower 15 extremity. The claimant should have no exposure to moving mechanical parts and 16 high, exposed place hazards, as rated by the Selective Characteristics of Occupations of the Dictionary of Occupational Titles (SCO-DOT). 17 18 (AR 23). 19 In considering Plaintiff’s symptoms and the extent to which these symptoms can reasonably 20 be accepted as consistent with objective medical evidence and other evidence, the ALJ noted the 21 two-step process as set forth in 20 C.F.R. § 404.1529 and SSR 16-3p, and 20 C.F.R. § 404.1520c. 22 Id. The ALJ found “[a]fter careful consideration of the evidence” that Plaintiff’s MDIs could 23 reasonably be expected to cause the alleged symptoms but that her statements concerning the 24 intensity, persistence, and limiting effects of symptoms are not entirely consistent with the 25 longitudinal treatment record. (AR 25). The ALJ, citing to Plaintiff’s hearing testimony, treatment
26 four areas of functioning is identified as either “no limitation,” “mild,” “moderate,” “marked,” or “extreme.” Id. To satisfy the paragraph B criteria, a claimant must have an “extreme” limitation 27 in at least one of the areas of mental functioning, or a “marked” limitation in at least two of the areas of mental functioning. Id. 1 notes, prior administrative medical findings, and activities of daily living, determined that the
2 evidence of record did not provide support for the existence of greater limitations above those
3 assessed in the RFC regarding Plaintiff’s impairments. (AR 25-29).
4 At step four, the ALJ determined that Plaintiff has past relevant work, under 20 C.F.R. §
5 404.1565, that s`h e could perform as a customer service clerk and work order sorting clerk. (AR 6 29). The ALJ therefore concluded a finding of “not disabled” was appropriate under sections 216(i) 7 and 223(d) of the Act from February 21, 2019, through the date of the decision. (AR 30). 8 B. Medical Record and Hearing Testimony 9 The relevant hearing testimony and medical record were reviewed by the Court and will be 10 referenced below as necessary to this Court’s decision. 11 II. LEGAL STANDARD 12 A district court’s review of a final decision of the Commissioner of Social Security is 13 governed by 42 U.S.C. § 405(g). The scope of review under § 405(g) is limited; the 14 Commissioner’s decision will be disturbed “only if it is not supported by substantial evidence or is 15 based on legal error.” Hill v. Astrue, 698 F.3d 1153, 1158 (9th Cir. 2012). “Substantial evidence” 16 means “relevant evidence that a reasonable mind might accept as adequate to support a 17 conclusion.” Id. at 1159 (quotation and citation omitted). Stated differently, substantial evidence 18 equates to “more than a mere scintilla[,] but less than a preponderance.” Id. (quotation and citation 19 omitted). “[I]t is such relevant evidence as a reasonable mind might accept as adequate to support 20 a conclusion.” Sandgathe v. Chater, 108 F.3d 978, 980 (9th Cir. 1997) (quotation and citation 21 omitted). In determining whether the standard has been satisfied, a reviewing court must consider 22 the entire record as a whole rather than searching for supporting evidence in isolation. Id. 23 The court will review only the reasons provided by the ALJ in the disability determination 24 and may not affirm the ALJ on a ground upon which she did not rely. Social Security Act § 205, 25 42 U.S.C. § 405(g). In reviewing a denial of benefits, a district court may not substitute its 26 judgment for that of the Commissioner. “The court will uphold the ALJ’s conclusion when the 27 evidence is susceptible to more than one rational interpretation.” Tommasetti v. Astrue, 533 F.3d 1 of an error that is harmless. Id. An error is harmless where it is “inconsequential to the [ALJ’s]
2 ultimate nondisability determination.” Id. (quotation and citation omitted). The party appealing
3 the ALJ’s decision generally bears the burden of establishing that it was harmed. Shinseki v.
4 Sanders, 556 U.S. 396, 409-10 (2009).
5 A claima`n t must satisfy two conditions to be considered “disabled” and eligible for benefits 6 within the meaning of the Social Security Act. First, the claimant must be “unable to engage in any 7 substantial gainful activity by reason of any medically determinable physical or mental impairment 8 which can be expected to result in death or which has lasted or can be expected to last for a 9 continuous period of not less than twelve months.” 42 U.S.C. § 1382c(a)(3)(A). Second, the 10 claimant’s impairment must be “of such severity that he is not only unable to do his previous 11 work[,] but cannot, considering his age, education, and work experience, engage in any other kind 12 of substantial gainful work which exists in the national economy.” 42 U.S.C. § 13 1382c(a)(3)(B). 14 The Commissioner has established a five-step sequential analysis to determine whether a 15 claimant satisfies the above criteria. See 20 C.F.R. § 416.920(a)(4)(i)-(v). At step one, the 16 Commissioner considers the claimant’s work activity. 20 C.F.R. § 416.920(a)(4)(i). If the claimant 17 is engaged in “substantial gainful activity,” the Commissioner must find that the claimant is not 18 disabled. 20 C.F.R. § 416.920(b). 19 If the claimant is not engaged in substantial gainful activity, the analysis proceeds to step 20 two. At this step, the Commissioner considers the severity of the claimant’s impairment. 20 C.F.R. 21 § 416.920(a)(4)(ii). If the claimant suffers from “any impairment or combination of impairments 22 which significantly limits [his or her] physical or mental ability to do basic work activities,” the 23 analysis proceeds to step three. 20 C.F.R. § 416.920(c). If the claimant’s impairment does not 24 satisfy this severity threshold, however, the Commissioner must find that the claimant is not 25 disabled. Id. 26 At step three, the Commissioner compares the claimant’s impairment to impairments 27 recognized by the Commissioner to be so severe as to preclude a person from engaging in 1 severe than one of the enumerated impairments, the Commissioner must find the claimant disabled
2 and award benefits. 20 C.F.R. § 416.920(d).
3 If the severity of the claimant’s impairment does not meet or exceed the severity of the
4 enumerated impairments, the Commissioner must pause to assess the claimant’s “residual
5 functional capac`i ty,” defined generally as the claimant’s ability to perform physical and mental 6 work activities on a sustained basis despite his or her limitations (20 C.F.R. § 416.945(a)(1)). 7 At step four, the Commissioner considers whether, in view of the claimant’s RFC, the 8 claimant is capable of performing work that he or she has performed in the past (past relevant 9 work). 20 C.F.R. § 416.920(a)(4)(iv). If the claimant is capable of performing past relevant work, 10 the Commissioner must find that the claimant is not disabled. 20 C.F.R. § 416.920(f). If the 11 claimant is incapable of performing such work, the analysis proceeds to step five. 12 At step five, the Commissioner considers whether, in view of the claimant’s RFC, the 13 claimant is capable of performing other work in the national economy. 20 C.F.R. § 14 416.920(a)(4)(v). In making this determination, the Commissioner must also consider vocational 15 factors such as the claimant’s age, education, and past work experience. Id. If the claimant is 16 capable of adjusting to other work, the Commissioner must find that the claimant is not disabled. 20 17 C.F.R. § 416.920(g)(1). If the claimant is not capable of adjusting to other work, the analysis 18 concludes with a finding that the claimant is disabled and is therefore entitled to benefits. Id. 19 The claimant bears the burden of proof at steps one through four above. Tackett v. Apfel, 20 180 F.3d 1094, 1098 (9th Cir. 1999). If the analysis proceeds to step five, the burden shifts to the 21 Commissioner to establish that (1) the claimant is capable of performing other work; and (2) such 22 work “exists in significant numbers in the national economy.” 20 C.F.R. § 416.960(c)(2); Beltran 23 v. Astrue, 700 F.3d 386, 389 (9th Cir. 2012). 24 III. ISSUES AND ANALYSIS 25 Plaintiff seeks judicial review of the Commissioner’s final decision denying her application. 26 Plaintiff asserts that the ALJ failed to offer any clear and convincing reasons for rejecting Plaintiff’s 27 subjective complaints. (Doc. 18 at 7-18). 1 1. Parties’ Contentions
2 Plaintiff asserts that the ALJ’s failure to “connect any specific portion of Blose’s testimony
3 to the parts of the record supporting the ALJ’s decision prevents the Court from determining
4 whether the ALJ’s decision was supported by substantial evidence.” (Doc. 18 at 11; citation
5 omitted). Plainti`f f argues that the ALJ’s “articulated rationale is simply to state a few times in the 6 decision that [] ‘her level of functioning is not as limiting as alleged and that the objective medical 7 findings are not fully consistent with the degree of impairment alleged by the claimant’” and that 8 Plaintiff’s subjective complaints beyond those included in the RFC are “not consistent with the 9 longitudinal objective medical evidence.” Id. at 13. Plaintiff contends that, as the ALJ found 10 fibromyalgia to be a severe impairment, the ALJ’s rejection of Plaintiff’s testimony based on a lack 11 of consistency with the objective evidence is legal error. Id. at 13-14. 12 Plaintiff further argues that, as the ALJ “did not articulate Blose’s sporadic daily activities 13 as reason to reject the testimony,” any such argument raised by Defendant may not be considered 14 by the Court. Even if the ALJ had articulated such reasons, Plaintiff provides that nothing in her 15 description of her limitations “indicate she is capable of maintaining substantial gainful work 16 activity” for eight hours each day and five days a week. Id. at 14-16 (citing AR 51-63). 17 Plaintiff also asserts that the ALJ mischaracterized the record in stating that Plaintiff did not 18 report to her treating providers her need to lie down three to four times per week for between two 19 and four hours per episode. Id. at 16-17 (citing AR 27). Plaintiff contends that, in fact, the record 20 supports that she did report this need and the ALJ’s finding to the contrary constitutes error. Id. at 21 17 (citing AR 372, 374, 468, 490). Plaintiff separately argues that the ALJ errored in noting that 22 Plaintiff has responded to treatment and thereby suggesting some improvement. Id. at 17. 23 Defendant asserts that the ALJ appropriately evaluated Plaintiff’s subjective complaints and 24 “relied upon several specific factors” to discount Plaintiff’s testimony, such as objective evidence, 25 inconsistent statements, and evidence of improvement, and “appropriately linked” said evidence to 26 her findings without need of inferential leaps. (Doc. 19 at 6). In support, Defendant refers to 27 findings in the ALJ’s decision, namely that the record showed complaints of intermittent or 1 in dosage with discontinuation of a narcotic pain medication in 2019, and Plaintiff’s descriptions
2 of her symptoms to treating providers was inconsistent with the allegations she set forth at the
3 hearing. Id. at 8.
4 Defendant argues that records possibly evidencing Plaintiff’s need to lie down described a
5 temporary period` of pain, rather than a need to lie down on a regular basis, as well as a period of 6 time already adjudicated in a prior decision. Id. at 9 (citing AR 27, 60, 73-87, 468, 490). Defendant 7 contends that the ALJ “acknowledged Plaintiff’s testimony of uncontrolled symptoms … while 8 also summarizing her reported [daily] activities” and doing so was permissible, namely in drawing 9 a “comparison between Plaintiff’s reported activities and her allegations of constant debilitating 10 symptoms.” Id. (citing AR 24-25, 52, 54, 58-59, 1074-75). 11 Defendant asserts that the ALJ “identified numerous specific factors to find Plaintiff less 12 limited than alleged” and that Plaintiff’s “over-arching argument is that the ALJ did nothing more 13 than summarize the medical evidence,” without linking such evidence to the ALJ’s discounting of 14 Plaintiff’s subjective symptom testimony. Defendant notes that the ALJ relied upon reports of 15 improvement with conservative treatment, inconsistent statements, and daily activities, and the 16 rationale in the decision was sufficiently clear for judicial review. Id. at 10-11. 17 Lastly, Defendant asserts that, regarding fibromyalgia, Plaintiff asserted the “only 18 conditions keeping her from returning to work were here gastrointestinal issues, which the ALJ 19 noted” and, as with all impairments, the ALJ must compare the consistency of Plaintiff’s alleged 20 symptoms of fibromyalgia with other evidence in the record. Id. at 11-12 (emphasis omitted; citing 21 AR 24, 58, 1077-78). 22 2. Governing Authority 23 The ALJ is responsible for determining credibility,3 resolving conflicts in medical 24
25 3 SSR 16-3p, which applies to disability applications heard by the agency on or after March 28, 2016, eliminated the use of the term “credibility” to emphasize that subjective symptom 26 evaluation “is not an examination of an individual’s character,” but an endeavor to determine how “symptoms limit an individual’s ability to perform work-related activities.” SSR 16-3p, 2017 WL 27 5180304, at *3. Nevertheless, the Ninth Circuit continues to reference an ALJ’s “credibility assessment” when reviewing claims that an ALJ impermissibly discounted a claimant's testimony. 1 testimony, and resolving ambiguities. Andrews v. Shalala, 53 F.3d 1035, 1039 (9th Cir. 1995). A
2 plaintiff’s statements of pain or other symptoms are not conclusive evidence of a physical or mental
3 impairment or disability. 42 U.S.C. § 423(d)(5)(A); see SSR 16-3p, 2017 WL 5180304, at *2 (“an
4 individual’s statements of symptoms alone are not enough to establish the existence of a physical
5 or mental impai`r ment or disability”); see also Orn v. Astrue, 495 F.3d 625, 635 (9th Cir. 2007) 6 (“An ALJ is not required to believe every allegation of disabling pain or other non-exertional 7 impairment.”) (internal quotation marks and citation omitted); Molina v. Astrue, 674 F.3d 1104, 8 1104 (9th Cir. 2012) (same), superseded on other grounds by 20 C.F.R. § 404.1502(a). 9 Determining whether a plaintiff’s testimony regarding subjective pain or symptoms is 10 credible requires the ALJ to engage in a two-step analysis. Id. at 1112. The ALJ must first 11 determine if “the [plaintiff] has presented objective medical evidence of an underlying impairment 12 which could reasonably be expected to produce the pain or other symptoms alleged.” Lingenfelter 13 v. Astrue, 504 F.3d 1028, 1036 (9th Cir. 2007) (internal punctuation and citations omitted). This 14 does not require the plaintiff to show that his impairment could be expected to cause the severity 15 of the symptoms that are alleged, but only that it reasonably could have caused some degree of 16 symptoms. Smolen v. Chater, 80 F.3d 1273, 1282 (9th Cir. 1996). 17 If the first step is met and there is no evidence of malingering, “the ALJ must provide 18 ‘specific, clear and convincing reasons for’ rejecting the [plaintiff’s] testimony.” Treichler v. 19 Comm’r of Soc. Sec., 775 F.3d 1090, 1102 (9th Cir. 2014) (quoting Smolen, 80 F.3d at 1281); see 20 Carmickle v. Comm’r of Soc. Sec., 533 F.3d 1155, 1160 (9th Cir. 2008) (noting an adverse 21 credibility finding must be based on “clear and convincing reasons”). The ALJ must make findings 22 that support this conclusion, and the findings must be sufficiently specific to allow a reviewing 23 court to conclude the ALJ rejected the plaintiff’s testimony on permissible grounds and did not 24 arbitrarily discredit the plaintiff’s testimony. Moisa v. Barnhart, 367 F.3d 882, 885 (9th Cir. 2004). 25 The Ninth Circuit does “not require ALJs to perform a line-by-line exegesis of the 26 [plaintiff’s] testimony, nor do they require ALJs to draft dissertations when denying benefits.” 27 Stewart v. Kijakazi, No. 1:22-cv-00189-ADA-HBK, 2023 WL 4162767, at *5 (E.D. Cal. Jun. 22, 1 Kijakazi, No. 1:22-cv-00495-BAM, 2023 WL 2752097, at *4 (E.D. Cal. Mar. 31, 2023) (“Even if
2 the ALJ’s decision is not a model of clarity, where the ALJ’s ‘path may reasonably be discerned,’
3 the Court will still defer to the ALJ’s decision.”) (quoting Wilson v. Berryhill, 757 Fed. App’x 595,
4 597 (9th Cir. 2019)). “The standard isn’t whether our court is convinced, but instead, whether the
5 ALJ’s rationale i`s clear enough that it has the power to convince.” Smartt v. Kijakazi, 53 F.4th 489, 6 494 (9th Cir. 2022) (noting that the clear and convincing standard requires an ALJ to show his 7 work). 8 The ALJ may consider numerous factors in weighing a plaintiff’s credibility, including “(1) 9 ordinary techniques of credibility evaluation, such as the [plaintiff’s] reputation for lying, prior 10 inconsistent statements concerning the symptoms, and other testimony by the [plaintiff] that 11 appears less than candid; (2) unexplained or inadequately explained failure to seek treatment or to 12 follow a prescribed course of treatment; and (3) the [plaintiff’s] daily activities.” Smolen, 80 F.3d 13 at 1284. In evaluating the credibility of symptom testimony, the ALJ must also consider the factors 14 identified in SSR 16-3P. Id. (citing Bunnell v. Sullivan, 947 F.2d 341, 346 (9th Cir. 1991)); accord 15 Bray v. Comm’r Soc. Sec., 554 F.3d 1219, 1227 (9th Cir. 2009). These factors include:
16 (1) Daily activities; (2) The location, duration, frequency, and intensity of pain or 17 other symptoms; (3) Factors that precipitate and aggravate the symptoms; (4) The type, dosage, effectiveness, and side effects of any medication an individual takes 18 or has taken to alleviate pain or other symptoms; (5) Treatment, other than medication, an individual receives or has received for relief of pain or other 19 symptoms; (6) Any measures other than treatment an individual uses or has used to relieve pain or other symptoms (e.g., lying flat on his or her back, standing for 15 20 to 20 minutes every hour, or sleeping on a board); and (7) Any other factors concerning an individual’s functional limitations and restrictions due to pain or 21 other symptoms. 22 SSR 16-3P, 2017 WL 5180304, at *7; see 20 C.F.R. § 404.1529(c)(3). If the ALJ’s finding is 23 supported by substantial evidence, the court may not engage in second-guessing. Tommasetti, 533 24 F.3d at 1039 (citations and internal quotation marks omitted). 25 The clear and convincing standard is “not an easy requirement to meet,” as it is “‘the most 26 demanding requirement in Social Security cases.’” Garrison v. Colvin, 759 F.3d 995, 1015 (9th 27 Cir. 2014) (quoting Moore v. Comm’r of Soc. Sec. Admin., 278 F.3d 920, 924 (9th Cir. 2002)). “A 1 reviewing court to conclude the adjudicator rejected the [plaintiff’s] testimony on permissible
2 grounds and did not arbitrarily discredit a [plaintiff’s] testimony regarding pain.” Brown-Hunter
3 v. Colvin, 806 F.3d 487, 493 (9th Cir. 2015) (citation and internal quotation marks omitted).
4 “The fact that a [plaintiff’s] testimony is not fully corroborated by the objective medical
5 findings, in and `o f itself, is not a clear and convincing reason for rejecting it.” Vertigan v. Halter, 6 260 F.3d 1044, 1049 (9th Cir. 2001); see 20 C.F.R. § 404.1529(c)(2) (“[W]e will not reject your 7 statements about the intensity and persistence of your pain or other symptoms or about the effect 8 your symptoms have on your ability solely because the objective medical evidence does not 9 substantiate your statements.”). Rather, where a plaintiff’s symptom testimony is not fully 10 substantiated by the objective medical record, the ALJ must provide additional reasons for 11 discounting the testimony. Burch v. Barnhart, 400 F.3d 676, 680 (9th Cir. 2005). “The ALJ must 12 specify what testimony is not credible and identify the evidence that undermines the [plaintiff’s] 13 complaints – ‘[g]eneral findings are insufficient.’” Id. (quoting Reddick v. Chater, 157 F.3d 715, 14 722 (9th Cir. 1998)). 15 However, the medical evidence “is still a relevant factor in determining the severity of the 16 [plaintiff’s] pain and its disabling effects.” Rollins v. Massanari, 261 F.3d 853, 857 (9th Cir. 2001). 17 The Ninth Circuit has distinguished testimony that is “uncorroborated” by the medical evidence 18 from testimony that is “contradicted” by the medical records and concluded that contradictions with 19 the medical records, by themselves, are enough to meet the clear and convincing standard. 20 Hairston v. Saul, 827 Fed. App’x 772, 773 (9th Cir. 2020) (quoting Carmickle, 533 F.3d at 1161). 21 3. Analysis 22 The ALJ summarized Plaintiff’s subjective symptom testimony from the hearing. (AR 24). 23 After finding that Plaintiff’s impairments could reasonably be expected to cause some of her alleged 24 symptoms, the ALJ concluded that Plaintiff’s statements concerning the intensity, persistence, and 25 limiting effects of his symptoms are not entirely consistent with the longitudinal treatment record. 26 (AR 25); see Treichler, 775 F.3d at 1103 (noting that ALJs “routinely include this [boilerplate] 27 statement in their written findings as an introduction ... before [identifying] what parts of the 1 During the hearing before the prior assigned ALJ Willner, counsel for Plaintiff asked
2 Plaintiff whether, “Separate from IBS, separate from the abdominal pain syndrome, do you have
3 any other problems that would limit you from returning to work separate from that?” Plaintiff
4 responded in the negative. Counsel then asked, “So, the complaints you have with your ankle, your
5 knee, elbow and` so on, those are like under control or at least managed at this time?” Plaintiff 6 responded in the affirmative. Counsel also asked Plaintiff, “So, weight-bearing knee issues, ankle 7 issues, is the knee, ankle or the elbow in your opinion restricting your return to work at this time or 8 is it just exclusively the IBS?” Plaintiff responded, “It’s the stomach pain and IBS.” (AR 1078). 9 Plaintiff did not include fibromyalgia as an additional reason for limitations on her ability to return 10 to work. 11 Plaintiff testified during that hearing that her IBS and abdominal pain symptoms had 12 worsened between the date of the hearing a year prior, stating that the “pain is less responsive to 13 the meds that [she] takes” and that the pain “never goes away.” (AR 1079-80). She testified the 14 abdominal pain rates between a two or a three, on a scale from zero to ten where ten represents the 15 most severe pain that may result in having to go to the emergency room, and that it can go as high 16 as a six or a seven, with possible daily fluctuations in intensity. (AR 1081). She also testified that 17 the abdominal pain arouses her from her sleep (AR 1082) and that her stamina is low, resulting in 18 her needing to sit down while doing daily tasks like cooking or vacuuming. (AR 1083). 19 Regarding bathroom usage, she attested that if she has diarrhea or constipation, she may use 20 the bathroom from five to 25 times or more in a day, and for as much as 15 minutes, with three to 21 four instances of diarrhea a week. She explained that her patten regarding usage of the bathroom 22 has worsened over the years since her prior hearing, namely in an increased number of visits per 23 week. (AR 1084-85). The longest time in aggregate she could be on her feet in any given day is 24 20 to 30 minutes, with the rest of her time spent sitting or lying down, and with two to four hours 25 of napping on three to five days a week, depending on pain. According to Plaintiff’s testimony, 26 this pattern has been ongoing for two or more years. (AR 1086). 27 During the hearing before the present assigned ALJ Rauenzahn, whose decision is before 1 the time of the prior hearing. Plaintiff stated that the pain in her stomach had gotten worse, in
2 regards to intensity, frequency, and duration, and that it “never goes away,” and that it “can be as
3 low as a two but it goes as high as an eight.” (AR 56-57). Plaintiff stated that “there’s been an
4 increase in [t]ramadol” regarding her use of medication to control the pain, and there are no days
5 in which she can` f orgo pain medication. (AR 57). Plaintiff reiterated that, apart from her abdominal 6 and gastric complaints, no other condition would limit her return to work. (AR 58). Plaintiff 7 provided that she laid down three to four times a week, anywhere from two to four hours at a time, 8 to alleviate some of the pain. (AR 60-61). 9 Plaintiff does not advance any arguments regarding the ALJ’s findings as to knee, ankle, or 10 elbow issues, or any other findings regarding symptom testimony in the decision, aside from those 11 relating to IBS, abdominal pain, and fibromyalgia. See (Doc. 18). 12 i. Preliminary Issues 13 First, as Plaintiff indicated at the hearing that her other impairments, aside from IBS and 14 abdominal pain, were not relevant as to limitations preventing her return to work, and Plaintiff fails 15 to advance any arguments in support, the Court will not address the ALJ’s finding as to these other 16 impairments. 17 Second, Plaintiff is correct that the ALJ did not analyze Plaintiff’s daily activities 18 specifically when rejecting her symptom testimony of record regarding worsened abdominal pain, 19 diarrhea, constipation, and her regular need to lie down. (Doc. 18 at 14); see (AR 24-27). Thus, 20 the Court will not reach any such argument by Defendant. (Doc. 19 at 9-10). 21 Third, as noted above, Plaintiff represented during the hearing that, apart from her 22 abdominal and gastric complaints, no other condition would limit her return to work. (AR 58). 23 Plaintiff did not mention fibromyalgia during the hearing. Though Plaintiff now mentions in her 24 motion fibromyalgia, she advances no argument besides the following conclusory sentence: “The 25 ALJ’s rejection of Blose’s testimony based on a lack of consistency with the objective evidence is 26 itself legal error in light of the severe fibromyalgia found by the ALJ.” (Doc. 18 at 14). As Plaintiff 27 mentioned symptom testimony regarding fibromyalgia neither in the hearing before the previous 1 related to abdominal and gastric complaints, the Court will not reach Plaintiff’s claim as raised in
2 her motion regarding fibromyalgia, particularly as Plaintiff fails to advance any arguments in
3 support.
4 ii. The ALJ’s Connection of the Analysis to the Relevant Testimony
5 Plaintiff `a sserts that the ALJ’s failure to “connect any specific portion of Blose’s testimony 6 to the parts of the record supporting the ALJ’s decision prevents the Court from determining 7 whether the ALJ’s decision was supported by substantial evidence.” (Doc. 18 at 11; citation 8 omitted). Plaintiff argues that “[a]t no point” did the ALJ identify the specific testimony that is 9 undermined by Plaintiff’s treatment history and that failure is legal error. Id. at 12. 10 As to these points, Plaintiff is incorrect. The ALJ does, in fact, connect Plaintiff’s testimony 11 to the analysis in the decision, in a manner sufficient for the Court to review whether the ALJ’s 12 decision was properly supported. As noted above, the ALJ is not required to “perform a line-by- 13 line exegesis of the [plaintiff’s] testimony,” nor must the ALJ “draft dissertations when denying 14 benefits.” Stewart, 2023 WL 4162767, at *5. If the ALJ’s “path may reasonable be discerned,” 15 the Court must still defer to the ALJ’s decision. Record, 2023 WL 2752097, at *4. 16 For example, the ALJ begins a portion of her analysis with the introductory statement, 17 “while the claimant alleges worsening abdominal pain,” followed by a finding that “the longitudinal 18 evidence suggests some improvement with Lyrica and improvement with relatively low-dose 19 [t]ramadol.” (AR 25). It is clear from the language of the ALJ’s decision on this point that she is 20 addressing the Plaintiff’s testimony regarding her worsening abdominal pain, before setting forth 21 the basis for her finding to discount said testimony. 22 Similarly, the ALJ begins another portion of her analysis with the introductory statement, 23 “[r]regarding irritable bowl syndrome (IBS)/chronic functional abdominal pain,” followed by a 24 finding that the “treatment record indicates some diarrhea complaints and alternating constipation 25 and diarrhea, but significantly worse diarrhea was reported during the claimant’s consultative 26 examination performed in connection with her application for employer-provided disability 27 insurance benefits.” (AR 25). Again, here, it is clear from the language of the decision that the 1 it relates, in context, to her need to use the bathroom.
2 The ALJ identifies the testimony to which she refers at the outset of each paragraph
3 detailing her analysis thereto. As further examples, she states that “the claimant testified that she
4 had an increase in her medications, specifically tramadol, since the last administrative law judge
5 decision was issu` ed,” prior to discussing this portion of the testimony. (AR 26-27). And the ALJ 6 states that “the claimant testified that she must lie down for three to four times per week for between 7 two and four hours per episode,” prior to discussing this portion of the testimony. (AR 27). 8 The ALJ’s analysis is connected to relevant portions of Plaintiff’s symptom testimony, 9 sufficient to allow the Court to discern the evidence upon which the ALJ relied to reject specific 10 portions of said testimony. See. e.g., Sevilla v. Kijakazi, No. CV 21-00331 JAO-WRP, 2022 WL 11 1302883, at *7 (D. Haw. May 2, 2022) (“While the ALJ’s Decision does not include a sentence 12 such as, ‘I reject Plaintiff’s testimony that he has difficulty leaving the house many days, because 13 X, Y, and Z reasons,’ an ALJ need not perform a line-by-line exegesis of the claimant’s testimony. 14 And the Court will not fault the agency merely for explaining its decision with less than ideal 15 clarity” so long as it is “sufficient to allow[ ] for meaningful review.”) (citations and quotations 16 omitted; alterations in original). 17 iii. The ALJ’s Evaluation of Plaintiff’s Symptom Testimony 18 Plaintiff asserts that the ALJ mischaracterized the record in stating that Plaintiff did not 19 report to her treating providers her need to lie down three to four times per week for between two 20 and four hours per episode and that the record supports that Plaintiff did report this need. (Doc. 18 21 at 16-17; citing AR 372, 374, 468, 490). Plaintiff also argues that the ALJ is incorrect in noting 22 that Plaintiff has responded to treatment and thereby suggesting some improvement, and that the 23 ALJ did not articulate daily activities as a rationale to reject her testimony and, even if the ALJ had, 24 it would have been insufficient. Plaintiff concludes that “[i]t is clear the ALJ’s sole rationale, that 25 the objective medical evidence did not support the testimony, is in and of itself [] insufficient to 26 reject the testimony.” (Doc. 18 at 17-18). 27 If the ALJ solely relied on objective medical evidence to reject the relevant symptom 1 Vertigan, 260 F.3d at 1049; 20 C.F.R. § 404.1529(c)(2). However, the ALJ’s citation to said
2 records does not, by itself, suggest the ALJ relied only on objective medical evidence in discounting
3 Plaintiff’s credibility. The medical evidence “is still a relevant factor in determining the severity
4 of the [plaintiff’s] pain and its disabling effects” (Rollins, 261 F.3d at 857) and an ALJ properly
5 may discount a `p laintiff’s symptomology testimony if she finds it is contradicted (not merely 6 unsupported) by identified medical records. Hairston, 827 Fed. App’x at 773. 7 a. Symptom Testimony Regarding Abdominal Pain, Diarrhea, and Constipation 8 Here, the ALJ cites to medical records for the proposition that “the record reveals no 9 complaints of significantly worsening pain to pain management or other providers, instead 10 reporting that her pain is improved or about the same.” The ALJ states that the “most recent noted 11 increase in subjective pain complaints occurred in January 2019 and April 2019” but that, “by 12 February 2019, the claimant was noted to be clinically stable and doing fairly well and the claimant 13 reported only a ‘dull’ ache in September 2019.” (AR 25; citing Exs. 3F, 21F, B2F-B5F, B10F- 14 B12F, B19F-B21F). The ALJ notes that Plaintiff’s statements to her physicians and to the Social 15 Security Administration “vary from her testimony at the hearing.” The ALJ states that though 16 Plaintiff “testified that her abdominal pain has worsened since the last [ALJ] decision was issued 17 with increased diarrhea episodes lasting … three to four times per week with five to 25 episodes 18 each day,” the record showed that Plaintiff had “not complained of significant and frequent diarrhea 19 episodes to her treating providers.” (AR 26). In support, the ALJ cites to medical records: AR 692 20 and 699 (for the finding that Plaintiff reported to her treatment provider “no episodes of diarrhea, 21 constipation, or abdominal pain”); AR 798 and 814 (for the finding that Plaintiff reported to her 22 treatment provider “no episodes of diarrhea, constipation, or abdominal pain”); and AR 1012-13 23 (for the finding that Plaintiff reported to her treatment provider “only ‘occasional’ diarrhea episodes 24 and … a ‘dull ache’ in the abdomen.”). 25 On September 12, 2019, physician Emeran A. Mayer records an appointment regarding 26 Plaintiff’s abdominal pain. Dr. Mayer states that Plaintiff was initially seen in 2016 for symptoms 27 of chronic abdominal pain and is “presenting with the same symptoms for treatment 1 summarized in my previous H&P from 4/11/2016,” before providing that Plaintiff “had
2 longstanding IBS symptoms … she describes her pain intensity fluctuating between 2-8/10 most
3 commonly 4-6/10,” and her “current symptoms are a dull ache over the abdomen … Symptoms are
4 distinctly different from her previous IBS symptoms of crampy, lower abdominal pain.” (AR
5 1012). Later in `t he record, Dr. Mayer notes that Plaintiff has “occasional diarrhea and urgency,” 6 “5 year history of chronic functional abdominal pain syndrome with some improvement on Lyrica,” 7 and that there “has been no change in my initial diagnosis of chronic abdominal pain syndrome …” 8 (AR 1013-14).4 9 This record does not fully support the ALJ’s conclusions. Although Plaintiff reports a “dull 10 ache” over the abdomen as her “current symptoms,” and notes only “occasional diarrhea,” such a 11 report is not entirely consistent with her testimony of three to four instances of diarrhea with five 12 to 25 visits to the bathroom. The record presents some ambiguity regarding overall conclusions as 13 to Plaintiff’s pain because it records only Plaintiff’s “current symptoms” and provides that her pain 14 intensity fluctuates in a manner similar to that described in her testimony. 15 On August 27, 2020, physician Hope Wildenberg records a follow-up appointment 16 regarding Plaintiff’s hypertension. Under the category “gastrointestinal,” Dr. Wildenberg states 17 “[n]egative for abdominal pain, heartburn, constipation, diarrhea, and stool changes.” (AR 692). 18 On September 10, 2020, Dr. Wildenberg records another visit by Plaintiff, presenting with hearing 19 loss on her left side. Under the category “gastrointestinal,” Dr. Wildenberg states “[n]egative for 20 abdominal pain, heartburn, constipation, diarrhea, and stool changes.” (AR 699). 21 On July 30, 2021, Dr. Wildenberg records a six-month follow-up visit. Under the category 22 “gastrointestinal,” Dr. Wildenberg states “[n]egative for abdominal pain; [n]egative for diarrhea; 23 [n]egative for constipation; [n]egative for nausea; [n]egative for vomiting.” (AR 814). On August 24 23, 2021, Dr. Wildenberg records an annual physical. Under the category “gastrointestinal,” Dr. 25 Wildenberg states “[n]egative for abdominal pain; [n]egative for diarrhea; [n]egative for 26 constipation; [n]egative for nausea; [n]egative for vomiting.” (AR 798). 27 Plaintiff is recorded as negative for abdominal pain, diarrhea, and constipation in four visits 1 from 2020 to 2021. These appointments are recent in time to the hearing and decision, with the
2 hearing before the present ALJ taking place on September 22, 2021, and the decision issued
3 November 3, 2021. (AR 30, 43). Thus, the appointments on July 30 and August 23, 2021, predate
4 the decision by approximately three months and two months, respectively. Additionally, the
5 appointment on `A ugust 23, 2021, is described as an annual physical and, presumably, is intended 6 to explore the Plaintiff’s general health at that time. In total, the records cited by the ALJ support 7 the conclusion that Plaintiff’s reports to physicians during her appointments contradicted her 8 testimony during the hearing regarding worsened abdominal pain, diarrhea and constipation. 9 In addition, during the hearing before the present ALJ, Plaintiff stated that “there’s been an 10 increase in [t]ramadol” regarding her use of medication to control the pain. (AR 57). In rejecting 11 this testimony, the ALJ stated that Plaintiff “did not receive a prescription for 50 milligrams of 12 tramadol until February 2020.” The ALJ provides that this prescription was on an as-needed basis 13 every six hours. The ALJ states that, otherwise, her tramadol prescription remained at the same 14 dose and on an “as-needed” frequency basis throughout the period under review, “suggesting that 15 this dose is adequate in controlling the claimant’s subjective pain.” (AR 26-27; citing AR 415, 16 561, 958). 17 In support, the ALJ cited to the medical record: AR 445 and 471 (for the finding that “in a 18 single isolated instance, the claimant reported to her treating physician in March 2020 that she 19 cannot tolerate tramadol and received a prescription for a heavier narcotic, Norco, on an as-needed 20 basis, despite reporting in November 2019 that Norco is not effective for her pain”); and AR (497 21 for the finding that “the claimant was prescribed Norco during the period addressed by the prior 22 administrative law judge, which does not support the claimant’s assertion that her pain medications 23 increased during the current period under review,” concluding that “the record better supports that 24 the claimant stopped taking a heavier narcotic, Norco, and was switched to a less heavy narcotic, 25 [t]ramadol, and Lyrica during the current period under review.”). (AR 27). 26 The documents annexed at AR 415 include a record by Dr. Wildenberg on October 2, 2019, 27 of a Lyrica prescription at a dosage of 200 milligrams. AR 561 includes a record by physician 1 every six hours as needed. AR 958 includes a record by physician Thomas Nasser on September
2 14, 2021, of a tramadol prescription at a dosage of 50 milligrams and a Lyrica prescription at a
3 dosage of 200 milligrams. AR 445 is a handwritten record with poor legibility and is difficult to
4 fully parse, rendering it ambiguous. However, AR 497 evidences a recording by Dr. Nasser of a
5 Norco prescripti`o n on June 26, 2018, predating the current period of review. AR 471 includes the 6 notation by Dr. Nasser on November 18, 2019, that Norco was discontinued due to being 7 ineffective. 8 In her motion, Plaintiff does not set forth any citations to the record regarding worsened 9 abdominal pain, diarrhea, or constipation, nor does Plaintiff offer any specific arguments 10 challenging the ALJ’s cited evidence in support. See (Doc. 18). 11 In citing to medical evidence contradicting Plaintiff’s statements, the ALJ supported the 12 rejection of Plaintiff’s symptom testimony regarding worsened abdominal pain, diarrhea, and 13 constipation with clear and convincing evidence. See Hairston, 827 Fed. App’x at 773. 14 b. Symptom Testimony Regarding Need to Lie Down 15 “An ALJ may consider a range of factors in assessing credibility, including (1) ordinary 16 techniques of credibility evaluation, such as the claimant’s reputation for lying, prior inconsistent 17 statements concerning the symptoms, and other testimony by the claimant that appears less than 18 candid; (2) unexplained or inadequately explained failure to seek treatment or to follow a prescribed 19 course of treatment; and (3) the claimant’s daily activities.” Ghanim v. Colvin, 763 F.3d 1154, 20 1163 (9th Cir. 2014). 21 As noted above, the ALJ rejected Plaintiff’s symptom testimony because it was inconsistent 22 with the medical evidence and Plaintiff’s “statements to her physicians and to the Social Security 23 Administration (SSA) vary from her testimony at hearing.” (AR 26). The ALJ cited to clear and 24 convincing evidence to conclude that Plaintiff’s claims were not credible. 25 During the hearing before the prior ALJ, Plaintiff stated that the longest time in aggregate 26 she could be on her feet in any given day is 20 to 30 minutes, with the rest of her time spent sitting 27 or lying down, and with two to four hours of napping on three to five days a week, depending on 1 hearing before the present ALJ, Plaintiff provided that she laid down three to four times a week,
2 anywhere from two to four hours at a time, to alleviate some of the pain. (AR 60-61).
3 In rejecting this testimony, the ALJ offered the following reasoning:
4 Additionally, although the claimant testified that she must lie down three to four times per week for between two and four hours per 5 ep` isode, the longitudinal record reveals that the claimant failed to 6 report this significantly limiting symptom to any of her treating providers throughout the period under review. Exs. (September 7 2021 Hearing Testimony); c.f. e.g. B2F through B21F; but see Ex. B1F (noting that the claimant endorsed needing to lie down when 8 undergoing an independent medical examination in connection with her application for employer-provided disability benefits). 9 10 (AR 27). 11 Plaintiff cites to the medical record for the proposition that the ALJ is wrong and Plaintiff 12 did, in fact, report her need to lie down to relieve pain to her treatment providers. (Doc. 18 at 17; 13 citing AR 372, 374, 468, 490). 14 The ALJ referred to two of the records identified by Plaintiff (AR 372 and 374) in the 15 reasoning noted above; said records are part of Exhibit B1F, which documents an independent 16 medical examination of Plaintiff for purposes of assessing disability. See (AR 363). It is clear 17 from the citation signals used by the ALJ that the ALJ is contrasting Plaintiff’s report of her need 18 to lie down during an independent medical examination intended to evaluate her disability, with 19 the lack of any such report to treatment providers outside of a disability-evaluation context. See, 20 e.g., Jodie W. v. Comm’r of Soc. Sec., No. C20-5117-MLP, 2021 WL 1192471, at *3 (W.D. Wash. 21 Mar. 30, 2021) (“Plaintiff misses the ALJ’s point: the ALJ noted that Plaintiff reported symptoms 22 during evaluations related to benefits eligibility that she did not report elsewhere … Regardless of 23 whether Plaintiff’s exaggeration of symptoms to DSHS examiners unequivocally demonstrates a 24 secondary gain motivation, this type of inconsistency is itself a convincing reason to discount a 25 claimant’s testimony.”) (citing Greger v. Barnhart, 464 F.3d 968, 972 (9th Cir. 2006)). 26 However, the ALJ’s statement that “the claimant failed to report this significantly limiting 27 symptom to any of her treating providers throughout the period under review” is not entirely supported by the record. The medical records at AR 468 and 490 identified Plaintiff’s indication 1 of lying down, at least one of those records falls within the period under review, and both records
2 are part of a continuous set of treatment records beginning prior to, and continuing into, the period
3 under review.
4 During an appointment for chronic abdominal pain on March 8, 2018, nurse practitioner
5 Maria Davis of A` vors Medical Group recorded that Plaintiff “still requires frequent periods of lying 6 down throughout the day to relieve pain despite medication …” (AR 490). During additional 7 appointments on December 11, 2018, on January 15, 2019, on June 7, 2019, on August 13, 2019, 8 and on September 23, 2019, Dr. Nasser, also of Avors Medical Group, recorded either that pain is 9 aggravated by walking, standing, bending, and sitting for prolonged periods, or that pain is 10 alleviated with rest. (AR 505, 510, 515, 520, 526, 532). 11 On November 18, 2019, for a follow-up visit regarding abdominal and lumbar pain, Dr. 12 Nasser records that Plaintiff reported her “pain has remained since last visit. Patient reports for the 13 past she has noted not be feeling very well [sic] and has been having to lay down ever day for the 14 past two weeks.” (AR 468). On February 24, 2020, medical records document Plaintiff’s follow- 15 up visit for abdominal and lumbar pain with Dr. Nasser. Though lying down and resting are not 16 mentioned, this record appears to be otherwise substantially similar to the aforementioned records 17 and continuing the same line of treatment. (AR 439). During a visit on June 1, 2020, Dr. Nasser 18 records that Plaintiff “reports of stomach pain flare ups, causing her to become bed rest [sic].” (AR 19 992). A later record from September 14, 2021, includes Dr. Nasser’s recording that Plaintiff’s 20 symptoms included abdominal pain and under the subcategory “Context” recorded prolonged 21 walking, standing, sitting, physical activity, and twisting, as well as sitting to standing motions. 22 (AR 957). 23 The period under review began on February 21, 2019. (AR 16). The records noted above 24 began prior to that date and continued the same line of treatment into the period of review, with 25 mention of a need to lie down on at least three occasions within the records overall (two within the 26 review period), and with numerous mentions of resting alleviating abdominal pain. The ALJ does 27 not discuss these records within the decision. See, e.g., Henderson v. Comm’r, Soc. Sec. Admin., 1 the opinion may be one factor the ALJ can consider in giving an opinion more or less weight, a
2 medical opinion is not insignificant or not probative merely because it is rendered prior to an alleged
3 onset date, particularly in cases where the claimant suffers from an ongoing impairment.”) (citing
4 Carmickle, 533 F.3d at 1165, & Williams v. Astrue, 493 F. App’x 866, 868-69 (9th Cir. 2012)).
5 Thus, the` ALJ erred in finding “the claimant failed to report this significantly limiting 6 symptom to any of her treating providers throughout the period under review.” (AR 27). 7 iv. The ALJ’s Harmless Error 8 An ALJ’s error may be harmless where she provides valid reasons for disbelieving a 9 plaintiff’s testimony in addition to invalid reasons. Molina, 674 F.3d at 1115 (citing cases). The 10 Ninth Circuit has articulated two different standards governing application of harmless error. See 11 Carmickle, 533 F.3d at 1162-63. Where an ALJ “errs in not providing any reasons supporting a 12 particular determination … the error is harmless if no reasonable ALJ could have reached a different 13 conclusion had the error not occurred. Otherwise, where the ALJ provides analysis but some part 14 of that analysis is flawed (i.e., some but not all of the reasons given for rejecting a claimant’s 15 credibility are either legally insufficient or unsupported by the record), … any error is harmless if 16 it is inconsequential to the ultimate decision because the ALJ’s disability determination nonetheless 17 remains valid.” Silvestre v. Comm’r of Soc. Sec., No. 2:17-CV-0539-CMK, 2018 WL 4096092, at 18 *4 (E.D. Cal. Aug. 28, 2018) (citing Carmickle, 533 F.3d at 1162-63). 19 Here, as noted in subsection (a), the ALJ began by providing analysis that Plaintiff’s IBS- 20 related symptom testimony was contrary to the medical evidence and her statements to her 21 physicians. The ALJ continues this line of analysis when discussing all of Plaintiff’s IBS-related 22 symptom testimony and supported those findings with clear and convincing evidence. The ALJ 23 then began her analysis on Plaintiff’s symptom testimony regarding the need to lie down with the 24 word “additionally.” It is sufficiently clear from the language used by the ALJ that she intended 25 for her analysis regarding the IBS-related symptoms from earlier in the decision, namely in the 26 contradictions between the symptom testimony and related medical evidence, to apply to her 27 discussion regarding Plaintiff’s symptom testimony on the need to lie down. See Brown-Hunter, 1 even if the agency explains its decision with less than ideal clarity”) (citation and quotation
2 omitted); see also Olivas v. Comm’r of Soc. Sec. Admin., No. CV 22-00278-TUC-BGM, 2023 WL
3 3749568, at *7 (D. Ariz. June 1, 2023) (“The Court agrees that it would be easier to follow the
4 ALJ’s reasoning if all the factors related to his analysis of Olivas’s subjective symptom testimony
5 appeared in the s`a me place. Nevertheless, reading the opinion as a whole, the ALJ’s reasoning can 6 be discerned.”). 7 The ALJ erred in finding that Plaintiff had failed to mention her need to lie down to her 8 medical providers in the period under review. However, the error is harmless as the ALJ provided 9 valid reasons to discount Plaintiff’s credibility as to her symptom testimony, namely in the 10 contradictions regarding the presence and severity of her limiting symptoms to which she testified 11 and her reports to and records of her medical providers. See Davary v. Kijakazi, No. 20-16750, 12 2023 WL 2134401, at *1 (9th Cir. Feb. 21, 2023) (“The ALJ provided specific, clear, and 13 convincing reasons to discount Davary’s symptom testimony by citing to record evidence that 14 contradicted Davary’s assertions and undermined the severity of the limitations alleged. … Any 15 error in the ALJ’s additional reasons for discounting Davary's testimony was harmless.”) (internal 16 citations omitted); Petty v. Colvin, No. CV-12-02289-PHX-BSB, 2014 WL 1116992, at *14 (D. 17 Ariz. Mar. 17, 2014) (finding that the ALJ “erred in rejecting Plaintiff’s subjective complaints 18 regarding urinary incontinence based on his characterization of her treatment modalities as 19 ‘limited’” but “he properly rejected Plaintiff’s complaints of disabling symptoms, including urinary 20 incontinence” for another reason, namely “based on the limited treatment Plaintiff received from 21 July 2009 through April 2010”). 22 Insofar as Plaintiff puts forth another rational interpretation of the record, “[w]here evidence 23 is susceptible to more than one rational interpretation, the ALJ’s decision should be upheld.” Orn 24 v. Astrue, 495 F.3d 625, 630 (9th Cir. 2007) (quotation omitted). 25 * * * * * 26 In sum, the ALJ’s error was harmless and the ALJ properly discounted Plaintiff’s symptom 27 testimony with clear and convincing evidence. 1 IV. CONCLUSION 2 Accordingly, IT IS HEREBY ORDERED that: 3 1. Plaintiff's motion for summary judgment (Doc. 18) is DENIED; 4 2. The ALJ’s decision is affirmed; and 5 3. The Clerk of the Court shall enter judgment in favor of Defendant, terminate any 6 deadlines, and close this case. 7 | ITIS SO ORDERED. S| Dated: _ January 13, 2026 | hannD Pr 9 UNITED STATES MAGISTRATE JUDGE 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 IA